Prelude Capital Management, LLC Terns Pharmaceuticals, Inc. Transaction History
Prelude Capital Management, LLC
- $1.39 Billion
- Q2 2024
A detailed history of Prelude Capital Management, LLC transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 32,087 shares of TERN stock, worth $274,343. This represents 0.02% of its overall portfolio holdings.
Number of Shares
32,087
Previous 84,619
62.08%
Holding current value
$274,343
Previous $555,000
60.72%
% of portfolio
0.02%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding TERN
# of Institutions
132Shares Held
63.4MCall Options Held
413KPut Options Held
106K-
Orbimed Advisors LLC San Diego, CA7.62MShares$65.1 Million1.25% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.18MShares$52.9 Million6.22% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.1MShares$52.2 Million1.36% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT4.95MShares$42.3 Million3.41% of portfolio
-
Black Rock Inc. New York, NY4.12MShares$35.2 Million0.0% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $322M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...